Target type: molecularfunction
Catalysis of the activation of the proteolytically processed small ubiquitin-related modifier SUMO, through the formation of an ATP-dependent high-energy thiolester bond. [GOC:rn, PMID:10187858, PMID:11265250]
SUMO activating enzyme activity, also known as E1 activity, is a crucial step in the SUMOylation pathway, a post-translational modification process that involves the covalent attachment of small ubiquitin-like modifier (SUMO) proteins to target proteins. The SUMO activating enzyme (SAE1/SAE2 heterodimer) catalyzes a two-step reaction that ultimately activates SUMO for conjugation:
1. **SUMO Adenylation:** The SAE1/SAE2 heterodimer binds to SUMO and uses ATP to adenylate the SUMO C-terminus, forming a SUMO-adenylate intermediate.
2. **SUMO Thioesterification:** The adenylated SUMO is then transferred to a cysteine residue on the SAE2 subunit, forming a SUMO-SAE2 thioester bond. This activated SUMO molecule is now primed for conjugation to target proteins.
The SUMO activating enzyme activity is essential for the proper functioning of the SUMOylation pathway, which plays a vital role in various cellular processes, including protein trafficking, DNA repair, signal transduction, and transcriptional regulation. Dysregulation of SUMO activating enzyme activity can lead to various diseases, including cancer and neurodegenerative disorders.'
"
Protein | Definition | Taxonomy |
---|---|---|
SUMO-activating enzyme subunit 2 | A SUMO-activating enzyme subunit 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UBT2] | Homo sapiens (human) |
SUMO-activating enzyme subunit 2 | A SUMO-activating enzyme subunit 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UBT2] | Homo sapiens (human) |
SUMO-activating enzyme subunit 2 | A SUMO-activating enzyme subunit 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UBT2] | Homo sapiens (human) |
SUMO-activating enzyme subunit 1 | A SUMO-activating enzyme subunit 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UBE0] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
anacardic acid | anacardic acid : A hydroxybenzoic acid that is salicylic acid substituted by a pentadecyl group at position 6. It is a major component of cashew nut shell liquid and exhibits an extensive range of bioactivities. anacardic acid: isolated from Anacardium occidentale; monophenol monooxygenase inhibitor | hydroxy monocarboxylic acid; hydroxybenzoic acid | anti-inflammatory agent; antibacterial agent; anticoronaviral agent; apoptosis inducer; EC 2.3.1.48 (histone acetyltransferase) inhibitor; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; neuroprotective agent; plant metabolite |
ginkgolic acid | hydroxybenzoic acid | ||
pevonedistat | pevonedistat : A pyrrolopyrimidine that is 7H-pyrrolo[2,3-d]pyrimidine which is substituted by a (1S)-2,3-dihydro-1H-inden-1-ylnitrilo group at position 4 and by a (1S,3S,4S)-3-hydroxy-4-[(sulfamoyloxy)methyl]cyclopentyl group at position 7. It is a potent and selective NEDD8-activating enzyme inhibitor with an IC50 of 4.7 nM, and currently under clinical investigation for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes. pevonedistat: a potent and selective inhibitor of NAE (NEDD8-activating enzyme) | cyclopentanols; indanes; pyrrolopyrimidine; secondary amino compound; sulfamidate | antineoplastic agent; apoptosis inducer |
largazole | largazole: an antiproliferative agent from Symploca; structure in first source |